The discovery of an arylsulfone hydroxamic acid template for the inhibition of phosphodiesterase type 4 and matrix metalloproteinases.

被引：0
|
作者：
Groneberg, RD [1 ]
Burns, CJ [1 ]
Condon, SM [1 ]
McGeehan, GM [1 ]
Ulrich, JW [1 ]
Morrissette, MM [1 ]
Morris, RL [1 ]
Djuric, SW [1 ]
机构：
[1] Rhone Poulenc Rorer, Collegeville, PA 19426 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1998年 / 216卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
001-MEDI
引用
收藏
页码：U201 / U201
页数：1
相关论文
共 50 条
  • [31] Pharmacophore Modeling and Virtual Screening for the Discovery of New type 4 cAMP Phosphodiesterase (PDE4) Inhibitors
    Niu, Miaomiao
    Dong, Fenggong
    Tang, Shi
    Fida, Guissi
    Qin, Jingyi
    Qiu, Jiadan
    Liu, Kangbo
    Gao, Weidong
    Gu, Yueqing
    PLOS ONE, 2013, 8 (12):
  • [32] Inhibition of chlorine-induced lung injury by the type 4 phosphodiesterase inhibitor rolipram
    Chang, Weiyuan
    Chen, Jing
    Schlueter, Connie F.
    Rando, Roy J.
    Pathak, Yashwant V.
    Hoyle, Gary W.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2012, 263 (02) : 251 - 258
  • [33] Inhibition of phosphodiesterase type 4 decreases stress-induced defecation in rats and mice
    Barone, Frank C.
    Barton, Matthew E.
    White, Ray F.
    Legos, Jeffrey J.
    Kikkawa, Hideo
    Shimamura, Midori
    Kuratani, Kazuyoshi
    Kinoshita, Mine
    PHARMACOLOGY, 2008, 81 (01) : 11 - 17
  • [34] Phosphodiesterase type 4 inhibition of activated polymorphonuclear leukocytes in a simulated extracorporeal circulation model
    Sato, Y
    Hiramatsu, Y
    Homma, S
    Sato, S
    Onizuka, M
    Sakakibara, Y
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (01): : 172 - 177
  • [35] Striking effect of hydroxamic acid substitution on the phosphodiesterase type 4 (PDE4) and TNFα inhibitory activity of two series of rolipram analogues:: Implications for a new active site model of PDE4
    Kleinman, EF
    Campbell, E
    Giordano, LA
    Cohan, VL
    Jenkinson, TH
    Cheng, JB
    Shirley, JT
    Pettipher, ER
    Salter, ED
    Hibbs, TA
    DiCapua, FM
    Bordner, J
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (03) : 266 - 270
  • [36] Inhibition of human leukocyte elastase, plasmin and matrix metalloproteinases by oleic acid and oleoyl-galardin derivative(s)
    Moroy, Gautier
    Bourguet, Erika
    Decarme, Martine
    Sapi, Janos
    Alix, Alain J. P.
    Hornebeck, William
    Lorimier, Sandrine
    BIOCHEMICAL PHARMACOLOGY, 2011, 81 (05) : 626 - 635
  • [37] Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type I-matrix metalloproteinase
    Bigg, HF
    Morrison, CJ
    Butler, GS
    Bogoyevitch, MA
    Wang, ZP
    Soloway, PD
    Overall, CM
    CANCER RESEARCH, 2001, 61 (09) : 3610 - 3618
  • [38] Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitors
    Martin-Chouly, CAE
    Astier, A
    Jacob, C
    Pruniaux, MP
    Bertrand, C
    Lagente, V
    LIFE SCIENCES, 2004, 75 (07) : 823 - 840
  • [39] Suppressive effect of phosphodiesterase type 4 inhibition on systemic inflammatory responses after cardiopulmonary bypass
    Hamamoto M.
    Suga M.
    Takahashi Y.
    Sato Y.
    Inamori S.
    Yagihara T.
    Nakatani T.
    Kitamura S.
    Journal of Artificial Organs, 2006, 9 (3) : 144 - 148
  • [40] Influence of the inhibition of cyclic nucleotide phosphodiesterase type 4 on human detrusor smooth muscle contractions
    Oger, S
    Behr-Roussel, D
    Bernabe, J
    Yvette, GS
    Denys, P
    Camperat, E
    Lebret, T
    Giuliano, FA
    JOURNAL OF UROLOGY, 2006, 175 (04): : 63 - 63
12345